Sarissa Biomedical
company
About
Sarissa is developing a range of minimally invasive, microelectrode electrochemical sensors for the measurement of the purines.
- 1 - 10
Details
- Last Funding Type
- Angel
- Industries
- Biotechnology,Health Care,Medical
- Founded date
- Jan 1, 2002
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Sarissa is developing a range of minimally invasive, microelectrode electrochemical sensors for the measurement of the purines and other neurochemicals, as indicators of neurological activity / disorders and has a product design platform that offers exquisite sensitivity, coupled with a broad linear range and high levels of accuracy and reproducibility. These biosensors are designed for in vitro and in vivo studies for research and diagnostic applications.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
£1.20M
Sarissa Biomedical has raised a total of
£1.20M
in funding over 2 rounds. Their latest funding was raised on
May 28, 2020 from a Series Unknown round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| May 28, 2020 | Series Unknown | £1.20M | 2 | — | — | Detail |
| Dec 1, 2010 | Angel | — | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
3
Sarissa Biomedical is funded by 3 investors.
The Wood Family
and Mercia’s EIS funds
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series Unknown |
|
|
— | Series Unknown |
Mercia Fund Managers
|
— | Angel |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
